Health Anti-CD39 Combination Therapy Promising in Gastric/GEJ Cancer Eli Pacheco Apr 14, 2022 0 NEW ORLEANS -- More than 60% of patients with unresectable gastric/gastroesophageal junction (GEJ) cancer responded to the…
